Clinical Trials Browser

Phase 1/2 × LY6K protein, human × Clear all

NCT00681252 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00681421 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT00681577 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00674258 2008-05-14

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung